Skip to content

Impact of Pregabalin in Chronic Users vs. a Perioperative Limited Prescription on Oxycodone Requirement

Postoperative Oxycodone Consumption After Spinal Surgery in Pregabalin-treated Patients Compared to a 48-h Perioperative Administration: a Prospective, Observational Study

Status
Completed
Phases
Unknown
Study type
Observational
Source
ClinicalTrials.gov
Registry ID
NCT02866396
Acronym
PREGAB
Enrollment
70
Registered
2016-08-15
Start date
2016-09-30
Completion date
2017-12-31
Last updated
2018-04-03

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Neuropathic Pain, Postoperative Pain

Keywords

chronic pain, oxycodone, pregabalin, lumbar spine surgery, multimodal analgesia

Brief summary

Spinal surgery is associated with intense pain and associated to a history of preoperative chronic pain. Pregabalin is licensed to treat chronic neuropathic pain, particularly when high dose of opioid are required. Preoperative pain is associated with high postoperative pain scores and opioid requirement promoting persistent hyperalgesic state. The investigators will evaluate the postoperative opioid consumption and pain scores in patients scheduled for lumbar surgery and taking pregabalin since more than 15 days and compare with preoperative pregabalin-free patient that will receive pregabalin only during surgery.

Detailed description

Patients will be prospectively included and compared according their preoperative medication: pregabalin-treated patients (\>more than 15 days) for neuropathic pain associated to spinal surgery and pregabalin-free patients for whom pregabalin will be prescribed for 48 hours. Patients will be included without randomization as an observational study. All the patients will receive multimodal analgesia and intraoperative management will be standardized. The main outcome will be the amount of oxycodone during the first 24h after surgery. Other outcomes include pain scores, the quantification of the neuropathic pain diagnostic questionnaire (DN4), nausea and vomiting, length of stay, side-effects of pregabalin and opioid. Patients were also evaluated at three months for pain scores and DN4 score. Postoperative evaluation will be performed in a single-blind manner with investigators not include in the recruitment or the peroperative period.

Interventions

DRUGPregabalin

Pregabalin continued at the same preoperative dose 1h before surgery associated to paracetamol 1g PO and ketoprofen 100mg PO Intraoperative: nefopam 20mg IV + ketamine 0.3mg/kg IV + dexamethasone 8mg IV Postoperative: morphine titration in PACU (NRS \> 3) + paracetamol 1g/6h PO + ketoprofen 100mg/12h PO systematically, oxycodone 5-10mg/12h PO if NRS\>3

OTHERNaive patient

Pregabalin 150mg PO initiated 1h before surgery Associated to paracetamol 1g PO and ketoprofen 100mg PO Intraoperative: nefopam 20mg IV + ketamine 0.3mg/kg IV + dexamethasone 8mg IV Postoperative: morphine titration in PACU (NRS \> 3) + paracetamol 1g/6h PO + ketoprofen 100mg/12h PO systematically, oxycodone 5-10mg/12h PO if NRS\>3

Sponsors

Rennes University Hospital
CollaboratorOTHER
Christophe Aveline, MD
Lead SponsorOTHER

Study design

Observational model
COHORT
Time perspective
PROSPECTIVE

Eligibility

Sex/Gender
ALL
Age
18 Years to 85 Years
Healthy volunteers
No

Inclusion criteria

* American Society Anesthesiologist Physical status (ASA) 1-3 * Age ≥18 years old * Spinal surgery: discectomy, posterior or transforaminal lumbar interbody fusion limited to 2 levels, lumbar disk prosthesis * Able to participate personality, has given free and inform consent in French * Affiliated of beneficiary of a system of social security

Exclusion criteria

* Age less than 18 years or higher than 85 years old * Refusal to participate or provide written consent * Surgery with a combined anterior and posterior approach * Emergency surgery, reintervention, spine fracture, metastasis * Tricyclic antidepressant use * Pregabalin use for other indication: other neuropathy, epilepsy, generalized anxiety disorder * Pregnancy * Lack of understanding of NRS and/or DN4 scores * Hypersensibility or contraindication to levobupivacaine, paracetamol, nefopam, ketoprofen and/or oxycodone * Participation in another clinical study

Design outcomes

Primary

MeasureTime frameDescription
Oxycodone consumption24h postoperativelymg

Secondary

MeasureTime frameDescription
Numeric Rating Scale (NRS) Pain during walkingthe day before surgeryNRS: 0 no pain - 10 worst pain
Numeric Rating Scale Pain (NRS) at rest1h after surgeryNRS: 0 no pain - 10 worst pain
Numeric Rating Scale Pain (NRS) during walking12h after surgeryNRS: 0 no pain - 10 worst pain
remifentanil consumptionduring surgeryµg/kg/min
Morphine titration0-2h after surgerymg
Oxycodone requirement0-48h after surgerymg
Numeric Rating Scale (NRS) Pain at restthe day before surgeryNRS: 0 no pain - 10 worst pain
DN4 scorepreoperatively
length of stayon postoperative day fivedays
Post Opertive Nausea and vomiting (PONV)0-48h after surgery% of patients
Pregabalin side-effects0-48h after surgerydiplopia, confusion, dizziness, psychiatric disorders (% of patients)
Sedation0-48h after surgery1: awake - 2: drowsiness, easily awake by appeal - 3: drowsiness, awake to tactile stimulation - 4: drowsiness, awake by pain
Ondansetron requirement0-48h after surgerymg

Countries

France

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026